State of the union: A review of state‐based laws and regulations supporting pharmacist payment for clinical services
Fuente:
Wiley Open Access
Salvato in:
| Natura: | Artículo Open Access |
|---|---|
| Pubblicazione: |
Wiley
2024
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Documenti analoghi
Evaluation of a psychiatric pharmacist consultation service in a multispecialty outpatient clinic
di: Deni Hui, et al.
Pubblicazione: (2024)
di: Deni Hui, et al.
Pubblicazione: (2024)
Identifying ideal pharmacist‐to‐patient ratios for the successful provision of clinical pharmacy services
di: Jay L. Martello, et al.
Pubblicazione: (2024)
di: Jay L. Martello, et al.
Pubblicazione: (2024)
The economic impact of the pharmacist in heart failure ambulatory care clinics: A scoping review
di: Justine Brasseur‐Masse, et al.
Pubblicazione: (2025)
di: Justine Brasseur‐Masse, et al.
Pubblicazione: (2025)
Evaluating a novel pharmacist‐led buprenorphine outreach service for treatment of opioid use disorder in individuals residing in supportive housing
di: Janice Ly, et al.
Pubblicazione: (2024)
di: Janice Ly, et al.
Pubblicazione: (2024)
Professional and career development needs of clinical pharmacists in settings outside academia
di: Sarah M. Hayes, et al.
Pubblicazione: (2024)
di: Sarah M. Hayes, et al.
Pubblicazione: (2024)
Nationwide evaluation of the clinical impact of acute care adult medicine pharmacists
di: Jennifer A. Szwak, et al.
Pubblicazione: (2024)
di: Jennifer A. Szwak, et al.
Pubblicazione: (2024)
A change to the pathway: The Impact of the Supreme Court of the United States affirmative action decision on clinical pharmacy and a call to action for pharmacists
di: Jacinda C. Abdul‐Mutakabbir, et al.
Pubblicazione: (2024)
di: Jacinda C. Abdul‐Mutakabbir, et al.
Pubblicazione: (2024)
Comment on “Professional and career development needs of clinical pharmacists in settings outside academia”
di: G. Christina Gutierrez, et al.
Pubblicazione: (2024)
di: G. Christina Gutierrez, et al.
Pubblicazione: (2024)
Evaluation of the value of board‐certified pharmacists in United States hospitals and the associated impact on clinical and operational measures: A cross‐sectional pilot study
di: Michael Stepanovic, et al.
Pubblicazione: (2025)
di: Michael Stepanovic, et al.
Pubblicazione: (2025)
Age‐based transitions of care: Where is the pharmacist?
di: Sara W. Hovey, et al.
Pubblicazione: (2024)
di: Sara W. Hovey, et al.
Pubblicazione: (2024)
Real‐world observations of using compounded GLP ‐1 ± GIP agonists within a clinical pharmacist‐managed cardiometabolic clinic
di: Shannon W. Finks, et al.
Pubblicazione: (2025)
di: Shannon W. Finks, et al.
Pubblicazione: (2025)
Impact of pharmacist management on chronic obstructive pulmonary disease in a family medicine residency clinic
di: Jacqueline Elaine Figueras, et al.
Pubblicazione: (2025)
di: Jacqueline Elaine Figueras, et al.
Pubblicazione: (2025)
Development and application of a toolkit for community pharmacist‐led review of patients with diabetes
di: Justine Borg, et al.
Pubblicazione: (2025)
di: Justine Borg, et al.
Pubblicazione: (2025)
Integrating clinical pharmacists into transitions of care: A qualitative study of barriers and facilitators among federally qualified health centers
di: Ben C. D. Weideman, et al.
Pubblicazione: (2024)
di: Ben C. D. Weideman, et al.
Pubblicazione: (2024)
EXaminaTion of cRitical cAre PHArmacist pRoductivity MetricS (EXTRA‐PHARMS): The clinical pharmacist's perspective
di: Christy Forehand, et al.
Pubblicazione: (2024)
di: Christy Forehand, et al.
Pubblicazione: (2024)
Implementation of a pharmacist‐driven chronic obstructive pulmonary disease transitions of care service at a large academic medical center
di: Maggie M. Lycouras, et al.
Pubblicazione: (2024)
di: Maggie M. Lycouras, et al.
Pubblicazione: (2024)
Comparative analysis of glycemic outcomes following implementation of a pharmacist‐led insulin management service in postoperative cardiothoracic surgery patients
di: Sydney Kermeen, et al.
Pubblicazione: (2025)
di: Sydney Kermeen, et al.
Pubblicazione: (2025)
HIV pre‐exposure prophylaxis champion preceptorship training for pharmacists and nurses in the United States
di: Parya Saberi, et al.
Pubblicazione: (2024)
di: Parya Saberi, et al.
Pubblicazione: (2024)
Evaluation of single maintenance and reliever therapy (SMART) prescribing of budesonide‐formoterol for asthma after a clinical pharmacist‐led initiative
di: Ila M. Harris, et al.
Pubblicazione: (2024)
di: Ila M. Harris, et al.
Pubblicazione: (2024)
Evaluation of hemoglobin A1c reduction in Hispanic patients versus non‐Hispanic patients with type 2 diabetes managed by a clinical pharmacist
di: Mayela Warner, et al.
Pubblicazione: (2025)
di: Mayela Warner, et al.
Pubblicazione: (2025)
Impact of internal medicine pharmacists on antimicrobial stewardship
di: Ashley Rizzo, et al.
Pubblicazione: (2024)
di: Ashley Rizzo, et al.
Pubblicazione: (2024)
Bridging the gap: A critical review to empower pharmacists to address disparities in type 2 diabetes prevention and management among African American men
di: Tyler Marie Kiles, et al.
Pubblicazione: (2025)
di: Tyler Marie Kiles, et al.
Pubblicazione: (2025)
National survey of transplant pharmacist ambulatory care practices
di: Helen Sweiss, et al.
Pubblicazione: (2024)
di: Helen Sweiss, et al.
Pubblicazione: (2024)
Insights on antifungal therapeutic drug monitoring from infectious diseases physicians and hospital‐based pharmacists: A focus group analysis
di: Annie Cheung, et al.
Pubblicazione: (2025)
di: Annie Cheung, et al.
Pubblicazione: (2025)
Unique model for pharmacist cross‐coverage in the ambulatory care setting
di: Anna Abrahamson, et al.
Pubblicazione: (2024)
di: Anna Abrahamson, et al.
Pubblicazione: (2024)
Long‐term effect of pharmacist‐led interventions on diabetes distress
di: Shae L. Martel, et al.
Pubblicazione: (2025)
di: Shae L. Martel, et al.
Pubblicazione: (2025)
Using a rule‐based decision tool for medication dose selection to improve patient safety and the need for pharmacist intervention
di: Tyler Finocchio, et al.
Pubblicazione: (2024)
di: Tyler Finocchio, et al.
Pubblicazione: (2024)
Evaluation of oral targeted anticancer drug interactions and their management by oncology pharmacists
di: Sarah L. Wede, et al.
Pubblicazione: (2024)
di: Sarah L. Wede, et al.
Pubblicazione: (2024)
Trends and considerations for interprofessional continuing education activities for pharmacists and pharmacy technicians
di: Logan T. Murry, et al.
Pubblicazione: (2025)
di: Logan T. Murry, et al.
Pubblicazione: (2025)
Perceptions, knowledge, and perceived barriers to practicing evidence‐based medicine among pharmacists in Japanese community hospitals: A cross‐sectional multicenter survey
di: Kiichi Enomoto, et al.
Pubblicazione: (2024)
di: Kiichi Enomoto, et al.
Pubblicazione: (2024)
Ambulatory care hematology/oncology pharmacy services: A comprehensive review by the Saudi Oncology Pharmacy Assembly
di: Nada Alsuhebany, et al.
Pubblicazione: (2024)
di: Nada Alsuhebany, et al.
Pubblicazione: (2024)
Remediation strategies for student pharmacists with socio‐behavioral issues in the experiential curriculum: A case series
di: Lindsey Dayer, et al.
Pubblicazione: (2024)
di: Lindsey Dayer, et al.
Pubblicazione: (2024)
Impact of interprofessional and simulation activities on student pharmacists' professional identity formation: A qualitative study
di: Christina H. Sherrill, et al.
Pubblicazione: (2025)
di: Christina H. Sherrill, et al.
Pubblicazione: (2025)
Empowering pharmacists with data: Steps toward proactive medication safety and quality improvement
di: Lara K. Ellinger, et al.
Pubblicazione: (2024)
di: Lara K. Ellinger, et al.
Pubblicazione: (2024)
Medication therapy management: The evolution of clinical pharmacy services in U.S. Community‐Based Pharmacy Practice—An opinion of the community‐based practice and research network of the American College of Clinical Pharmacy
di: Emily Eddy, et al.
Pubblicazione: (2024)
di: Emily Eddy, et al.
Pubblicazione: (2024)
Pharmacist certification of drug therapy modification: A survey of pharmacist‐reported practices, facilitators, and barriers in Georgia
di: Rebecca H. Stone, et al.
Pubblicazione: (2024)
di: Rebecca H. Stone, et al.
Pubblicazione: (2024)
Evaluating the impact of pharmacist counseling on patient satisfaction and willingness to pay: A study in the Pakistan health care context
di: Asma Ghulam Mustafa, et al.
Pubblicazione: (2024)
di: Asma Ghulam Mustafa, et al.
Pubblicazione: (2024)
Evaluating practitioner attitudes toward pharmacist clinician prescribing of buprenorphine for the treatment of opioid use disorder
di: Miguel Lopez, et al.
Pubblicazione: (2025)
di: Miguel Lopez, et al.
Pubblicazione: (2025)
A tale of two bills: Lessons learned in expanding pharmacist‐led HIV pre‐exposure and post‐exposure prophylaxis
di: Jennifer Cocohoba, et al.
Pubblicazione: (2024)
di: Jennifer Cocohoba, et al.
Pubblicazione: (2024)
Retrospective cohort study of ambulatory care pharmacist interventions’ impact on incidence of therapeutic response in anxiety and depression
di: Ashlyn M. Kiebach, et al.
Pubblicazione: (2024)
di: Ashlyn M. Kiebach, et al.
Pubblicazione: (2024)
Documenti analoghi
-
Evaluation of a psychiatric pharmacist consultation service in a multispecialty outpatient clinic
di: Deni Hui, et al.
Pubblicazione: (2024) -
Identifying ideal pharmacist‐to‐patient ratios for the successful provision of clinical pharmacy services
di: Jay L. Martello, et al.
Pubblicazione: (2024) -
The economic impact of the pharmacist in heart failure ambulatory care clinics: A scoping review
di: Justine Brasseur‐Masse, et al.
Pubblicazione: (2025) -
Evaluating a novel pharmacist‐led buprenorphine outreach service for treatment of opioid use disorder in individuals residing in supportive housing
di: Janice Ly, et al.
Pubblicazione: (2024) -
Professional and career development needs of clinical pharmacists in settings outside academia
di: Sarah M. Hayes, et al.
Pubblicazione: (2024)